Gene Symbol | Gene ID | Gene Info |
---|---|---|
SRF
|
ENSG00000112658.6 | serum response factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_43138501_43138804 | SRF | 385 | 0.786329 | -0.64 | 6.3e-02 | Click! |
chr6_43140630_43141425 | SRF | 899 | 0.462382 | -0.51 | 1.6e-01 | Click! |
chr6_43141521_43141708 | SRF | 1486 | 0.287844 | 0.51 | 1.6e-01 | Click! |
chr6_43142607_43142932 | SRF | 2641 | 0.179829 | -0.50 | 1.7e-01 | Click! |
chr6_43138020_43138466 | SRF | 794 | 0.515173 | -0.46 | 2.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_71950232_71950471 | 0.99 |
SAR1A |
SAR1 homolog A (S. cerevisiae) |
20072 |
0.17 |
chr11_111391090_111391372 | 0.99 |
C11orf88 |
chromosome 11 open reading frame 88 |
5721 |
0.11 |
chr7_46297529_46297680 | 0.93 |
ENSG00000239004 |
. |
282567 |
0.01 |
chr19_13142471_13142622 | 0.88 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
6735 |
0.11 |
chr6_35457763_35458156 | 0.86 |
TEAD3 |
TEA domain family member 3 |
6768 |
0.17 |
chr10_112170567_112171063 | 0.86 |
ENSG00000221359 |
. |
23184 |
0.2 |
chr15_51602118_51602364 | 0.84 |
CYP19A1 |
cytochrome P450, family 19, subfamily A, polypeptide 1 |
8448 |
0.17 |
chr1_202003645_202003796 | 0.84 |
RP11-510N19.5 |
|
23222 |
0.1 |
chr4_47527226_47527524 | 0.83 |
AC092597.3 |
|
34901 |
0.16 |
chr10_95195819_95196061 | 0.82 |
MYOF |
myoferlin |
46011 |
0.14 |
chr6_136399735_136399886 | 0.79 |
RP13-143G15.3 |
|
5845 |
0.27 |
chr2_122121802_122122094 | 0.77 |
CLASP1 |
cytoplasmic linker associated protein 1 |
63098 |
0.13 |
chr9_138952025_138952443 | 0.74 |
NACC2 |
NACC family member 2, BEN and BTB (POZ) domain containing |
9808 |
0.22 |
chr12_111873433_111874308 | 0.74 |
SH2B3 |
SH2B adaptor protein 3 |
1204 |
0.47 |
chr3_112323833_112324096 | 0.74 |
CCDC80 |
coiled-coil domain containing 80 |
5163 |
0.24 |
chrY_2545355_2545506 | 0.74 |
ENSG00000251841 |
. |
107360 |
0.07 |
chrX_2595353_2595504 | 0.73 |
CD99 |
CD99 molecule |
13792 |
0.22 |
chr11_130767618_130767831 | 0.73 |
SNX19 |
sorting nexin 19 |
3955 |
0.35 |
chr2_173860682_173860978 | 0.73 |
RAPGEF4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
30524 |
0.2 |
chr5_43294641_43294792 | 0.71 |
CTD-2636A23.2 |
|
5219 |
0.23 |
chr5_141998017_141998291 | 0.71 |
FGF1 |
fibroblast growth factor 1 (acidic) |
2753 |
0.29 |
chr2_85504705_85504985 | 0.71 |
ENSG00000221579 |
. |
21312 |
0.12 |
chr14_53330178_53330329 | 0.70 |
FERMT2 |
fermitin family member 2 |
986 |
0.61 |
chr4_26050932_26051083 | 0.70 |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
114070 |
0.07 |
chr8_96814534_96814685 | 0.70 |
ENSG00000223297 |
. |
123466 |
0.06 |
chr4_141860055_141860206 | 0.69 |
RNF150 |
ring finger protein 150 |
58060 |
0.15 |
chr2_33382763_33382914 | 0.68 |
LTBP1 |
latent transforming growth factor beta binding protein 1 |
23114 |
0.25 |
chr5_119876090_119876241 | 0.68 |
PRR16 |
proline rich 16 |
9006 |
0.32 |
chr2_23634355_23634506 | 0.67 |
KLHL29 |
kelch-like family member 29 |
26342 |
0.26 |
chr15_51401320_51401471 | 0.67 |
TNFAIP8L3 |
tumor necrosis factor, alpha-induced protein 8-like 3 |
3922 |
0.27 |
chr9_74599531_74599682 | 0.67 |
C9orf85 |
chromosome 9 open reading frame 85 |
73029 |
0.09 |
chr7_2802071_2802373 | 0.67 |
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12 |
552 |
0.83 |
chr17_73075198_73075684 | 0.67 |
SLC16A5 |
solute carrier family 16 (monocarboxylate transporter), member 5 |
8381 |
0.09 |
chr14_59800029_59800257 | 0.67 |
ENSG00000252869 |
. |
66598 |
0.11 |
chr18_20872031_20872182 | 0.67 |
RP11-17J14.2 |
|
31788 |
0.2 |
chr8_26123678_26123924 | 0.66 |
PPP2R2A |
protein phosphatase 2, regulatory subunit B, alpha |
25206 |
0.23 |
chr1_219259694_219259888 | 0.66 |
LYPLAL1 |
lysophospholipase-like 1 |
87395 |
0.1 |
chr2_202999119_202999270 | 0.66 |
AC079354.3 |
|
17413 |
0.15 |
chr4_95470032_95470452 | 0.66 |
PDLIM5 |
PDZ and LIM domain 5 |
25366 |
0.27 |
chr6_132452737_132452888 | 0.66 |
ENSG00000265669 |
. |
16409 |
0.27 |
chr11_76327363_76327514 | 0.66 |
AP001189.4 |
|
40662 |
0.14 |
chr1_68306464_68306615 | 0.65 |
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
7389 |
0.22 |
chr2_36659694_36659845 | 0.65 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
76155 |
0.1 |
chr17_64419381_64419532 | 0.65 |
RP11-4F22.2 |
|
6484 |
0.26 |
chr1_185941378_185941529 | 0.65 |
HMCN1 |
hemicentin 1 |
199066 |
0.03 |
chr2_227276660_227276915 | 0.65 |
ENSG00000263363 |
. |
246722 |
0.02 |
chr8_41570885_41571036 | 0.64 |
ANK1 |
ankyrin 1, erythrocytic |
7263 |
0.19 |
chr11_130273396_130273575 | 0.64 |
ADAMTS8 |
ADAM metallopeptidase with thrombospondin type 1 motif, 8 |
25403 |
0.2 |
chr16_83723296_83723447 | 0.64 |
RP11-298D21.3 |
|
28132 |
0.16 |
chr15_90121530_90121681 | 0.64 |
TICRR |
TOPBP1-interacting checkpoint and replication regulator |
2787 |
0.21 |
chr15_70995885_70996036 | 0.64 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
346 |
0.92 |
chr2_36639522_36639673 | 0.62 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
55983 |
0.15 |
chr2_20001512_20001663 | 0.61 |
TTC32 |
tetratricopeptide repeat domain 32 |
99815 |
0.08 |
chr3_160191590_160191741 | 0.61 |
ENSG00000238427 |
. |
1461 |
0.35 |
chr12_6338128_6338295 | 0.61 |
ENSG00000202318 |
. |
5410 |
0.19 |
chr18_56664990_56665141 | 0.61 |
ENSG00000251870 |
. |
71537 |
0.1 |
chr13_32662235_32662386 | 0.61 |
FRY |
furry homolog (Drosophila) |
27309 |
0.22 |
chr1_95332085_95332236 | 0.61 |
SLC44A3 |
solute carrier family 44, member 3 |
727 |
0.68 |
chr1_59482045_59482243 | 0.60 |
JUN |
jun proto-oncogene |
232359 |
0.02 |
chr4_151201855_151202006 | 0.60 |
LRBA |
LPS-responsive vesicle trafficking, beach and anchor containing |
21933 |
0.25 |
chr15_83874173_83874324 | 0.60 |
HDGFRP3 |
Hepatoma-derived growth factor-related protein 3 |
2522 |
0.27 |
chr12_117302328_117302479 | 0.60 |
HRK |
harakiri, BCL2 interacting protein (contains only BH3 domain) |
16490 |
0.21 |
chr16_64443886_64444184 | 0.60 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
649546 |
0.0 |
chr1_178908514_178908665 | 0.60 |
RALGPS2 |
Ral GEF with PH domain and SH3 binding motif 2 |
53375 |
0.13 |
chr17_46559333_46559484 | 0.60 |
ENSG00000206805 |
. |
2949 |
0.17 |
chr6_160123078_160123229 | 0.59 |
SOD2 |
superoxide dismutase 2, mitochondrial |
8793 |
0.15 |
chr18_57488970_57489121 | 0.59 |
ENSG00000221471 |
. |
72136 |
0.1 |
chr9_116940584_116940813 | 0.59 |
COL27A1 |
collagen, type XXVII, alpha 1 |
10703 |
0.21 |
chr1_245928780_245928931 | 0.59 |
RP11-522M21.3 |
|
89075 |
0.09 |
chr5_14193033_14193184 | 0.59 |
TRIO |
trio Rho guanine nucleotide exchange factor |
9201 |
0.32 |
chr7_134592506_134592657 | 0.58 |
CALD1 |
caldesmon 1 |
12656 |
0.27 |
chr11_73849202_73849353 | 0.58 |
C2CD3 |
C2 calcium-dependent domain containing 3 |
32752 |
0.14 |
chr3_58975517_58975668 | 0.58 |
C3orf67 |
chromosome 3 open reading frame 67 |
52104 |
0.18 |
chr11_102026582_102026733 | 0.58 |
YAP1 |
Yes-associated protein 1 |
30155 |
0.15 |
chr2_24051637_24051788 | 0.57 |
ATAD2B |
ATPase family, AAA domain containing 2B |
3769 |
0.31 |
chr5_34686863_34687019 | 0.57 |
RAI14 |
retinoic acid induced 14 |
451 |
0.87 |
chr21_46880431_46880582 | 0.57 |
COL18A1 |
collagen, type XVIII, alpha 1 |
5082 |
0.21 |
chr5_61440086_61440237 | 0.57 |
ENSG00000251983 |
. |
2331 |
0.45 |
chr11_61656018_61656169 | 0.57 |
FADS3 |
fatty acid desaturase 3 |
2290 |
0.2 |
chr3_194296927_194297078 | 0.57 |
TMEM44-AS1 |
TMEM44 antisense RNA 1 |
7738 |
0.15 |
chr5_177975146_177975297 | 0.56 |
COL23A1 |
collagen, type XXIII, alpha 1 |
14018 |
0.22 |
chr7_41045186_41045337 | 0.56 |
AC005160.3 |
|
230104 |
0.02 |
chr16_69238182_69238401 | 0.56 |
ENSG00000200164 |
. |
13265 |
0.12 |
chr15_35598915_35599148 | 0.56 |
ENSG00000265102 |
. |
65534 |
0.14 |
chr11_13156552_13156703 | 0.56 |
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
141572 |
0.04 |
chr6_86173167_86173318 | 0.56 |
NT5E |
5'-nucleotidase, ecto (CD73) |
7857 |
0.27 |
chr20_43223275_43223491 | 0.56 |
PKIG |
protein kinase (cAMP-dependent, catalytic) inhibitor gamma |
12193 |
0.15 |
chr1_154163009_154163193 | 0.56 |
TPM3 |
tropomyosin 3 |
1433 |
0.23 |
chr2_213708215_213708366 | 0.55 |
ENSG00000221388 |
. |
79891 |
0.1 |
chr17_53504679_53504830 | 0.55 |
MMD |
monocyte to macrophage differentiation-associated |
5401 |
0.32 |
chr12_66050940_66051359 | 0.55 |
HMGA2 |
high mobility group AT-hook 2 |
166762 |
0.03 |
chr5_146910957_146911108 | 0.55 |
DPYSL3 |
dihydropyrimidinase-like 3 |
21413 |
0.26 |
chr7_127417436_127417587 | 0.55 |
SND1 |
staphylococcal nuclease and tudor domain containing 1 |
110454 |
0.06 |
chr18_33746577_33746728 | 0.54 |
RP11-49I11.1 |
|
20759 |
0.16 |
chr18_43363682_43364023 | 0.54 |
RP11-116O18.3 |
|
36672 |
0.14 |
chr3_23536791_23536942 | 0.54 |
ENSG00000265645 |
. |
14797 |
0.26 |
chr1_17963278_17963429 | 0.53 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
18504 |
0.26 |
chr13_97925911_97926062 | 0.53 |
MBNL2 |
muscleblind-like splicing regulator 2 |
2472 |
0.41 |
chr5_16913937_16914088 | 0.53 |
MYO10 |
myosin X |
2624 |
0.32 |
chr10_101671643_101671794 | 0.53 |
DNMBP |
dynamin binding protein |
2121 |
0.33 |
chr11_35562990_35563282 | 0.53 |
PAMR1 |
peptidase domain containing associated with muscle regeneration 1 |
11288 |
0.25 |
chr20_8203734_8203885 | 0.52 |
PLCB1-IT1 |
PLCB1 intronic transcript 1 (non-protein coding) |
25542 |
0.25 |
chr2_27543666_27543963 | 0.52 |
MPV17 |
MpV17 mitochondrial inner membrane protein |
1617 |
0.19 |
chr13_110971974_110972125 | 0.52 |
COL4A2 |
collagen, type IV, alpha 2 |
12435 |
0.21 |
chr3_143774181_143774332 | 0.52 |
C3orf58 |
chromosome 3 open reading frame 58 |
81806 |
0.11 |
chr6_144570022_144570173 | 0.52 |
UTRN |
utrophin |
36740 |
0.19 |
chr9_21837231_21837382 | 0.52 |
MTAP |
methylthioadenosine phosphorylase |
17417 |
0.17 |
chr4_126309256_126309407 | 0.52 |
FAT4 |
FAT atypical cadherin 4 |
5760 |
0.29 |
chr2_214052779_214052930 | 0.52 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
35703 |
0.22 |
chr5_155564195_155564346 | 0.52 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
189486 |
0.03 |
chr4_81228117_81228268 | 0.51 |
C4orf22 |
chromosome 4 open reading frame 22 |
28682 |
0.2 |
chr14_55768736_55768887 | 0.51 |
FBXO34 |
F-box protein 34 |
29939 |
0.18 |
chr17_56031434_56032135 | 0.51 |
CUEDC1 |
CUE domain containing 1 |
834 |
0.58 |
chr9_97758309_97758460 | 0.51 |
C9orf3 |
chromosome 9 open reading frame 3 |
8031 |
0.21 |
chr3_185531728_185531979 | 0.51 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
6996 |
0.24 |
chr1_32819059_32819503 | 0.51 |
TSSK3 |
testis-specific serine kinase 3 |
226 |
0.89 |
chr10_30151041_30151192 | 0.51 |
SVIL |
supervillin |
126383 |
0.05 |
chr15_33121833_33121984 | 0.50 |
FMN1 |
formin 1 |
58547 |
0.12 |
chr12_54414078_54414229 | 0.50 |
HOXC4 |
homeobox C4 |
3438 |
0.08 |
chr16_87136109_87136260 | 0.50 |
RP11-899L11.3 |
|
113337 |
0.06 |
chr1_214689137_214689772 | 0.50 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
35112 |
0.22 |
chr6_42067452_42067603 | 0.50 |
C6orf132 |
chromosome 6 open reading frame 132 |
42655 |
0.1 |
chr6_44040423_44041032 | 0.49 |
RP5-1120P11.1 |
|
1662 |
0.35 |
chr3_149180351_149180502 | 0.49 |
TM4SF4 |
transmembrane 4 L six family member 4 |
11335 |
0.21 |
chr12_43709758_43710210 | 0.49 |
ENSG00000215993 |
. |
24601 |
0.27 |
chr5_153003397_153003548 | 0.49 |
ENSG00000242976 |
. |
131470 |
0.05 |
chr15_33093451_33093719 | 0.49 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
70693 |
0.09 |
chr8_69837050_69837201 | 0.49 |
ENSG00000238808 |
. |
185684 |
0.03 |
chr9_111397417_111397568 | 0.48 |
ACTL7B |
actin-like 7B |
221747 |
0.02 |
chr6_2468842_2468993 | 0.48 |
ENSG00000266252 |
. |
59048 |
0.15 |
chr12_79943500_79943651 | 0.48 |
ENSG00000243714 |
. |
24625 |
0.19 |
chr19_39150000_39150519 | 0.48 |
ACTN4 |
actinin, alpha 4 |
11881 |
0.12 |
chr12_52167059_52167210 | 0.48 |
AC068987.1 |
HCG1997999; cDNA FLJ33996 fis, clone DFNES2008881 |
36655 |
0.17 |
chr9_36332681_36332832 | 0.48 |
GNE |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
55703 |
0.12 |
chr12_16505710_16505975 | 0.47 |
MGST1 |
microsomal glutathione S-transferase 1 |
509 |
0.85 |
chr7_104607919_104608070 | 0.47 |
ENSG00000251911 |
. |
3740 |
0.23 |
chr20_1800907_1801169 | 0.47 |
SIRPA |
signal-regulatory protein alpha |
74116 |
0.1 |
chr8_32962851_32963002 | 0.47 |
ENSG00000265562 |
. |
90429 |
0.09 |
chr3_188669250_188669401 | 0.47 |
TPRG1 |
tumor protein p63 regulated 1 |
4322 |
0.37 |
chr12_91577880_91578031 | 0.47 |
DCN |
decorin |
1055 |
0.66 |
chr5_158477621_158478266 | 0.47 |
EBF1 |
early B-cell factor 1 |
48758 |
0.14 |
chr6_145569007_145569263 | 0.47 |
ENSG00000221796 |
. |
100759 |
0.09 |
chr3_184918393_184918544 | 0.47 |
EHHADH-AS1 |
EHHADH antisense RNA 1 |
37779 |
0.14 |
chr18_395353_395504 | 0.46 |
RP11-720L2.2 |
|
28988 |
0.2 |
chr8_79844807_79844958 | 0.46 |
IL7 |
interleukin 7 |
127124 |
0.06 |
chr4_14112329_14112480 | 0.46 |
ENSG00000252092 |
. |
452153 |
0.01 |
chr1_68640592_68640743 | 0.46 |
ENSG00000221203 |
. |
8626 |
0.22 |
chr5_81561436_81561587 | 0.46 |
RPS23 |
ribosomal protein S23 |
12649 |
0.23 |
chr10_6243827_6244661 | 0.46 |
RP11-414H17.5 |
|
412 |
0.58 |
chr7_22630355_22630506 | 0.46 |
AC002480.4 |
|
1106 |
0.52 |
chr12_104253506_104253657 | 0.46 |
RP11-650K20.3 |
Uncharacterized protein |
18352 |
0.14 |
chr22_35842229_35842380 | 0.46 |
MCM5 |
minichromosome maintenance complex component 5 |
45880 |
0.14 |
chr5_121518992_121519276 | 0.46 |
CTC-441N14.1 |
|
27424 |
0.17 |
chr4_26371195_26371346 | 0.46 |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
7118 |
0.32 |
chr2_1576886_1577037 | 0.46 |
AC144450.1 |
|
46924 |
0.17 |
chr5_135390329_135390480 | 0.46 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
4134 |
0.24 |
chr6_88416816_88416967 | 0.46 |
AKIRIN2 |
akirin 2 |
4964 |
0.22 |
chr11_94809865_94810123 | 0.46 |
ENDOD1 |
endonuclease domain containing 1 |
12980 |
0.21 |
chr8_74282582_74282920 | 0.46 |
RP11-434I12.2 |
|
14055 |
0.25 |
chr14_75688690_75688954 | 0.45 |
ENSG00000252013 |
. |
19950 |
0.14 |
chr6_113198313_113198464 | 0.45 |
ENSG00000201386 |
. |
94307 |
0.09 |
chr8_69991685_69991836 | 0.45 |
ENSG00000238808 |
. |
31049 |
0.26 |
chr3_27610112_27610263 | 0.45 |
ENSG00000238912 |
. |
20838 |
0.22 |
chr9_12880763_12880914 | 0.45 |
ENSG00000222658 |
. |
4482 |
0.3 |
chr10_30800294_30800445 | 0.45 |
ENSG00000239744 |
. |
44464 |
0.15 |
chr20_43696508_43696659 | 0.45 |
KCNS1 |
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 |
33167 |
0.12 |
chr3_174985020_174985171 | 0.44 |
NAALADL2-AS2 |
NAALADL2 antisense RNA 2 |
3790 |
0.34 |
chr2_36932543_36932694 | 0.44 |
VIT |
vitrin |
8598 |
0.25 |
chr14_65148512_65148745 | 0.44 |
PLEKHG3 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
22192 |
0.19 |
chr3_16145872_16146023 | 0.44 |
GALNT15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
70209 |
0.12 |
chr13_94997091_94997242 | 0.44 |
ENSG00000212057 |
. |
120478 |
0.06 |
chr14_71709495_71709775 | 0.44 |
AC004817.1 |
HCG2028611; Uncharacterized protein |
26173 |
0.21 |
chr14_73212557_73212708 | 0.44 |
ENSG00000206751 |
. |
107407 |
0.07 |
chr6_86155572_86155723 | 0.44 |
NT5E |
5'-nucleotidase, ecto (CD73) |
4162 |
0.33 |
chr13_98508497_98508648 | 0.44 |
ENSG00000238407 |
. |
29491 |
0.24 |
chr16_64126268_64126419 | 0.43 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
967238 |
0.0 |
chr13_27454838_27454989 | 0.43 |
GPR12 |
G protein-coupled receptor 12 |
119991 |
0.06 |
chr22_44707279_44707430 | 0.43 |
KIAA1644 |
KIAA1644 |
1377 |
0.54 |
chr18_66106660_66106811 | 0.43 |
TMX3 |
thioredoxin-related transmembrane protein 3 |
275559 |
0.02 |
chr8_129553232_129553525 | 0.43 |
ENSG00000221351 |
. |
278662 |
0.01 |
chr10_100134588_100134739 | 0.43 |
ENSG00000221419 |
. |
20401 |
0.18 |
chr2_29286777_29286928 | 0.43 |
C2orf71 |
chromosome 2 open reading frame 71 |
10275 |
0.14 |
chr2_40573732_40573883 | 0.43 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
83613 |
0.1 |
chr7_22854826_22854977 | 0.43 |
TOMM7 |
translocase of outer mitochondrial membrane 7 homolog (yeast) |
7062 |
0.23 |
chr1_82173200_82173351 | 0.43 |
LPHN2 |
latrophilin 2 |
7820 |
0.3 |
chr4_39116331_39116482 | 0.43 |
KLHL5 |
kelch-like family member 5 |
11471 |
0.19 |
chr2_37687823_37688242 | 0.43 |
ENSG00000253078 |
. |
25281 |
0.21 |
chr4_26143484_26143734 | 0.43 |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
21468 |
0.28 |
chr6_106702782_106702933 | 0.43 |
ENSG00000244710 |
. |
28729 |
0.17 |
chr3_60728480_60728631 | 0.42 |
ENSG00000212211 |
. |
113722 |
0.07 |
chr22_36828593_36829238 | 0.42 |
ENSG00000252575 |
. |
6056 |
0.16 |
chr18_2654403_2655150 | 0.42 |
SMCHD1 |
structural maintenance of chromosomes flexible hinge domain containing 1 |
961 |
0.5 |
chr14_56792280_56792431 | 0.42 |
TMEM260 |
transmembrane protein 260 |
162717 |
0.04 |
chr11_128298881_128299249 | 0.42 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
76224 |
0.11 |
chr4_95334230_95334509 | 0.42 |
PDLIM5 |
PDZ and LIM domain 5 |
38668 |
0.2 |
chr16_17498688_17498839 | 0.41 |
XYLT1 |
xylosyltransferase I |
65975 |
0.15 |
chr14_76289523_76289812 | 0.41 |
RP11-270M14.4 |
|
13887 |
0.25 |
chr18_55802231_55802473 | 0.41 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
14213 |
0.25 |
chr4_72254922_72255073 | 0.41 |
SLC4A4 |
solute carrier family 4 (sodium bicarbonate cotransporter), member 4 |
50227 |
0.19 |
chr5_78317290_78317441 | 0.41 |
DMGDH |
dimethylglycine dehydrogenase |
32698 |
0.16 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.3 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.3 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.2 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.0 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.0 | 0.2 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.0 | 0.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.4 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.1 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.0 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.0 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.0 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.0 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.0 | 0.0 | GO:0043096 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.0 | GO:0072182 | nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.1 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.0 | 0.1 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.0 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.0 | 0.1 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.0 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.0 | 0.0 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.0 | 0.0 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.0 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0071800 | podosome assembly(GO:0071800) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.0 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.0 | 0.1 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.0 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.1 | GO:0044319 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.0 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.0 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:0043302 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.0 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.0 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.0 | 0.0 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.0 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
0.0 | 0.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.0 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.4 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.3 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.2 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.6 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.0 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.0 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.6 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.3 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.3 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.0 | 0.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.4 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.0 | 0.0 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.0 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |